Tags

Type your tag names separated by a space and hit enter

Inclusion of transgender and gender diverse health data in cancer biorepositories.
Contemp Clin Trials Commun. 2020 Sep; 19:100597.CC

Abstract

Biobanks have the potential to be robust resource for understanding potential cancer risks associated with gender-affirming interventions. In this narrative review, we synthesized the current published literature regarding the inclusion of TGD health data in cancer biorepositories and cancer research conducted on biospecimens. Of the 6986 initial results, 153 (2.2%) assessed the biological effects of gender-affirming interventions on TGD tissues. Within that category, only one paper examined transgender tissues in relation to cancer biobanks. Strategies are offered to address the inequities in TGD tissue-based research and diversify the field of biobanking as a whole.

Authors+Show Affiliations

University of South Florida, Morsani College of Medicine, Tampa, FL, USA. H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.New York University Grossman School of Medicine, New York, NY, USA.University of South Florida, Morsani College of Medicine, Tampa, FL, USA. H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32613134

Citation

Jones, Nat C., et al. "Inclusion of Transgender and Gender Diverse Health Data in Cancer Biorepositories." Contemporary Clinical Trials Communications, vol. 19, 2020, p. 100597.
Jones NC, Otto AK, Ketcher DE, et al. Inclusion of transgender and gender diverse health data in cancer biorepositories. Contemp Clin Trials Commun. 2020;19:100597.
Jones, N. C., Otto, A. K., Ketcher, D. E., Permuth, J. B., Quinn, G. P., & Schabath, M. B. (2020). Inclusion of transgender and gender diverse health data in cancer biorepositories. Contemporary Clinical Trials Communications, 19, 100597. https://doi.org/10.1016/j.conctc.2020.100597
Jones NC, et al. Inclusion of Transgender and Gender Diverse Health Data in Cancer Biorepositories. Contemp Clin Trials Commun. 2020;19:100597. PubMed PMID: 32613134.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Inclusion of transgender and gender diverse health data in cancer biorepositories. AU - Jones,Nat C, AU - Otto,Amy K, AU - Ketcher,Dana E, AU - Permuth,Jennifer B, AU - Quinn,Gwendolyn P, AU - Schabath,Matthew B, Y1 - 2020/06/16/ PY - 2019/12/17/received PY - 2020/06/04/revised PY - 2020/06/14/accepted PY - 2020/7/3/entrez PY - 2020/7/3/pubmed PY - 2020/7/3/medline KW - Biospecimens KW - LGBT KW - SGM KW - Transgender persons SP - 100597 EP - 100597 JF - Contemporary clinical trials communications JO - Contemp Clin Trials Commun VL - 19 N2 - Biobanks have the potential to be robust resource for understanding potential cancer risks associated with gender-affirming interventions. In this narrative review, we synthesized the current published literature regarding the inclusion of TGD health data in cancer biorepositories and cancer research conducted on biospecimens. Of the 6986 initial results, 153 (2.2%) assessed the biological effects of gender-affirming interventions on TGD tissues. Within that category, only one paper examined transgender tissues in relation to cancer biobanks. Strategies are offered to address the inequities in TGD tissue-based research and diversify the field of biobanking as a whole. SN - 2451-8654 UR - https://www.unboundmedicine.com/medline/citation/32613134/Inclusion_of_transgender_and_gender_diverse_health_data_in_cancer_biorepositories L2 - https://linkinghub.elsevier.com/retrieve/pii/S2451-8654(20)30081-8 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.